{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T18:31:01Z","timestamp":1789583461535,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T00:00:00Z","timestamp":1469232000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s40264-016-0444-7","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T08:50:59Z","timestamp":1469263859000},"page":"847-857","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":147,"title":["Adverse-Drug-Reaction-Related Hospitalisations in Developed and Developing Countries: A Review of Prevalence and Contributing Factors"],"prefix":"10.1007","volume":"39","author":[{"given":"Mulugeta Tarekegn","family":"Angamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin M.","family":"Curtain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke R. E.","family":"Bereznicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,7,23]]},"reference":[{"key":"444_CR1","volume-title":"Safety of medicine: a guide to detecting and reporting adverse drug reaction","author":"World Health Organisation (WHO)","year":"2002","unstructured":"World Health Organisation (WHO). Safety of medicine: a guide to detecting and reporting adverse drug reaction. Geneva: WHO; 2002."},{"key":"444_CR2","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/j.1365-2125.2007.03064.x","volume":"65","author":"K Wester","year":"2008","unstructured":"Wester K, Jonsson AK, Spigset O, Druid H, Hagg S. Incidence of fatal adverse drug reactions: a population based study. Br J Clin Pharmacol. 2008;65:573\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"444_CR3","first-page":"273","volume":"19","author":"M Sonal Sekhar","year":"2011","unstructured":"Sonal Sekhar M, Adheena Mary C, Anju PG, Hamsa NA. Study on drug related hospital admissions in a tertiary care hospital in South India. Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2011;19:273\u20138.","journal-title":"Saudi Pharm J SPJ Off Publ Saudi Pharm Soc."},{"key":"444_CR4","first-page":"347","volume":"30","author":"FR Varallo","year":"2011","unstructured":"Varallo FR, Lima MFR, Galduroz JCF, Mastroianni PC. Adverse drug reaction as cause of hospital admission of elderly people: a pilot study. Latin Am J Pharm. 2011;30:347\u201353.","journal-title":"Latin Am J Pharm."},{"key":"444_CR5","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1365-2125.2007.03034.x","volume":"65","author":"U Mehta","year":"2008","unstructured":"Mehta U, Durrheim DN, Blockman M, Kredo T, Gounden R, Barnes KI. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV\/AIDS prevalence: prospective observational study. Br J Clin Pharmacol. 2008;65:396\u2013406.","journal-title":"Br J Clin Pharmacol"},{"key":"444_CR6","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, Cesari M, Della Vedova C, Bernabei R, Gambassi G. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50:1962\u20138.","journal-title":"J Am Geriatr Soc"},{"key":"444_CR7","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00228-010-0866-6","volume":"66","author":"JF S\u00e1nchez Mu\u00f1oz-Torrero","year":"2010","unstructured":"S\u00e1nchez Mu\u00f1oz-Torrero JF, Barquilla P, Velasco R, Fern\u00e1ndez Capitan MDC, Pacheco N, Vicente L, Chic\u00f3n JL, Trejo S, Zamorano J, Lorenzo Hernandez A. Adverse drug reactions in internal medicine units and associated risk factors. Eur J Clin Pharmacol. 2010;66:1257\u201364.","journal-title":"Eur J Clin Pharmacol."},{"key":"444_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2165\/00002018-200831090-00007","volume":"31","author":"Y Zopf","year":"2008","unstructured":"Zopf Y, Rabe C, Neubert A, Hahn EG, Dormann H. Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals. Drug Saf. 2008;31:789\u201398.","journal-title":"Drug Saf"},{"key":"444_CR9","first-page":"236","volume":"35","author":"C Perez Menendez-Conde","year":"2011","unstructured":"Perez Menendez-Conde C, Bermejo Vicedo T, Delgado Silveira E, Carretero Accame E. Adverse drug reactions which provoke hospital admission. Farmacia Hospitalaria Organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria. 2011;35:236\u201343.","journal-title":"Farmacia Hospitalaria Organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria."},{"key":"444_CR10","first-page":"83","volume":"22","author":"MJ Alomar","year":"2014","unstructured":"Alomar MJ. Factors affecting the development of adverse drug reactions (review article). Saudi Pharm J SPJ Off Publ Saudi Pharm Soc. 2014;22:83\u201394.","journal-title":"Saudi Pharm J SPJ Off Publ Saudi Pharm Soc."},{"key":"444_CR11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1136\/bmj.38803.528113.55","volume":"332","author":"SE McDowell","year":"2006","unstructured":"McDowell SE, Coleman JJ, Ferner R. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ. 2006;332:1177\u201381.","journal-title":"BMJ."},{"key":"444_CR12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.5414\/CP201514","volume":"49","author":"C Hofer-Dueckelmann","year":"2011","unstructured":"Hofer-Dueckelmann C, Prinz E, Beindl W, Szymanski J, Fellhofer G, Pichler M, Schuler J. Adverse drug reactions (ADRs) associated with hospital admissions\u2014elderly female patients are at highest risk. Int J Clin Pharmacol Ther. 2011;49:577\u201386.","journal-title":"Int J Clin Pharmacol Ther"},{"key":"444_CR13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1093\/ageing\/29.1.35","volume":"29","author":"CK Mannesse","year":"2000","unstructured":"Mannesse CK, Derkx FHM, de Ridder MAJ, t Veld A, van der Cammen TJM. Contribution of adverse drug reactions to hospital admission of older patients. Age Ageing. 2000;29:35\u20139.","journal-title":"Age Ageing."},{"key":"444_CR14","unstructured":"European Commission. Pharmacovigilance Impact Assessment. 2008. http:\/\/ec.europa.eu\/health\/files\/pharmacos\/pharmpack_12_2008\/pharmacovigilance-ia-vol1_en.pdf . Accessed on 10 June 2016."},{"key":"444_CR15","first-page":"2079","volume":"9","author":"TM Alhawassi","year":"2014","unstructured":"Alhawassi TM, Krass I, Bajorek BV, Pont LG. A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. 2014;9:2079\u201386.","journal-title":"Clin Interv Aging"},{"key":"444_CR16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"IR Edwards","year":"2000","unstructured":"Edwards IR, Aronson JK. Adverse drug reactions: definitions, diagnosis, and management. Lancet. 2000;356:1255\u20139.","journal-title":"Lancet."},{"key":"444_CR17","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, Janecek E, Domecq C, Greenblatt DJ. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"444_CR18","unstructured":"World Health Organisation (WHO). The use of the WHO-UMC system for standardised case causality assessment via http:\/\/who-umc.org\/Graphics\/24734.pdf ."},{"key":"444_CR19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bcp.12293","volume":"78","author":"A Al Hamid","year":"2014","unstructured":"Al Hamid A, Ghaleb M, Aljadhey H, Aslanpour Z. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014;78:202\u201317.","journal-title":"Br J Clin Pharmacol."},{"key":"444_CR20","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1023\/A:1015570104121","volume":"24","author":"HJ Beijer","year":"2002","unstructured":"Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): A meta-analysis of observational studies. Pharm World Sci. 2002;24:46\u201354.","journal-title":"Pharm World Sci"},{"key":"444_CR21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2125.2006.02698.x","volume":"63","author":"R Howard","year":"2007","unstructured":"Howard R, Avery A, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol. 2007;63:136\u201347.","journal-title":"Br J Clin Pharmacol."},{"key":"444_CR22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1345\/aph.1L037","volume":"42","author":"C Kongkaew","year":"2008","unstructured":"Kongkaew C, Noyce PR, Ashcroft DM. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. Ann Pharmacother. 2008;42:1017\u201325.","journal-title":"Ann Pharmacother"},{"key":"444_CR23","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz B, Corey P. Incidence of adverse drug reactions in hospitalised patients. a meta-analysis of prospective studies. J Am Med Assoc. 1998;279:1200\u20135.","journal-title":"J Am Med Assoc"},{"key":"444_CR24","first-page":"1","volume":"101","author":"P Wiffen","year":"2002","unstructured":"Wiffen P, Gill M, Edwards J, Moore A. Adverse drug reactions in hospital patients. A systematic review of the prospective and retrospective studies. Bandolier Extra. 2002;101:1\u201315.","journal-title":"Bandolier Extra"},{"key":"444_CR25","first-page":"1","volume":"2012","author":"O Dimie","year":"2012","unstructured":"Dimie O, Reginald OO, Haruna MM, Mukhtar A, Aliyu B, Abdulaziz H, Isa B, Henry I, Matthew I, Eric TA. Morbidity and mortality patterns of hospitalised adult HIV\/AIDS patients in the era of highly active antiretroviral therapy: a 4-year retrospective review from Zaria. Northern Nigeria. AIDS Res Treat. 2012;2012:1\u201311.","journal-title":"Northern Nigeria. AIDS Res Treat."},{"key":"444_CR26","first-page":"1","volume":"12","author":"NL Henry","year":"2012","unstructured":"Henry NL, Marie-Solange D, Simeon-Pierre C, Elvis T, Gloria A, Henry A, Sinata K-S. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study. Pan Afr Med J. 2012;12:1\u20137.","journal-title":"Pan Afr Med J."},{"key":"444_CR27","doi-asserted-by":"crossref","first-page":"349312","DOI":"10.1155\/2012\/349312","volume":"2012","author":"J Olmen Van","year":"2012","unstructured":"Van Olmen J, Schellevis F, Van Damme W, Kegels G, Rasschaert F. Management of chronic diseases in Sub-Saharan Africa: cross-fertilisation between HIV\/AIDS and diabetes care. J Trop Med. 2012;2012:349312.","journal-title":"J Trop Med."},{"key":"444_CR28","unstructured":"CIA.Country comparison: life expectancy at birth. 2015. https:\/\/www.cia.gov\/library\/publications\/the-world-factbook\/rankorder\/2102rank.html . Accessed on 9 June 2016 at 5:50PM."},{"key":"444_CR29","unstructured":"World Health Organisation (WHO). Counterfeit medicines: an update on estimates. 2006. http:\/\/www.who.int\/medicines\/services\/counterfeit\/impact\/TheNewEstimatesCounterfeit.pdf . Accessed on June 2016."},{"key":"444_CR30","first-page":"2229","volume":"49","author":"SC Hartwig","year":"1992","unstructured":"Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229\u201332.","journal-title":"Am J Hosp Pharm."},{"key":"444_CR31","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/qshc.2004.010611","volume":"13","author":"T Morimoto","year":"2004","unstructured":"Morimoto T, Gandhi TK, Seger AC, Hsieh TC, Bates DW. Adverse drug events and medication errors: detection and classification methods. Qual Saf Health Care. 2004;13:306\u201314.","journal-title":"Qual Saf Health Care."},{"key":"444_CR32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2796.1990.tb00199.x","volume":"228","author":"J Hallas","year":"1990","unstructured":"Hallas J, Harvald B, Gram LF, Grodum E, Brosen K, Haghfelt T, Damsbo N. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med. 1990;228:83\u201390.","journal-title":"J Intern Med"},{"key":"444_CR33","first-page":"538","volume":"27","author":"GT Schumock","year":"1992","unstructured":"Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992;27:538.","journal-title":"Hosp Pharm."},{"key":"444_CR34","first-page":"11","volume-title":"Textbook of adverse drug reactions","author":"MD Rawlins","year":"1981","unstructured":"Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In: Davies DM, editor. Textbook of adverse drug reactions. Oxford: Oxford University Press; 1981. p. 11."},{"key":"444_CR35","unstructured":"World Bank. Comparing levels of development. 1995. http:\/\/www.worldbank.org\/depweb\/beyond\/beyondco\/beg_02.pdf . Accessed on Dec 22 2015 at 3:00PM."},{"key":"444_CR36","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2165\/00002018-200629020-00006","volume":"29","author":"CS Hooft Van der","year":"2006","unstructured":"Van der Hooft CS, Sturkenboom MC, Van Grootheest K, Kingma HJ, Stricker BH. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf. 2006;29:161\u20138.","journal-title":"Drug Saf"},{"key":"444_CR37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00228-013-1630-5","volume":"70","author":"C Pedros","year":"2014","unstructured":"Pedros C, Quintana B, Rebolledo M, Porta N, Vallano A, Arnau JM. Prevalence, risk factors and main features of adverse drug reactions leading to hospital admission. Eur J Clin Pharmacol. 2014;70:361\u20137.","journal-title":"Eur J Clin Pharmacol"},{"key":"444_CR38","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/pds.2118","volume":"20","author":"D Rottenkolber","year":"2011","unstructured":"Rottenkolber D, Schmiedl S, Rottenkolber M, Farker K, Salje K, Mueller S, Hippius M, Thuermann PA, Hasford J. Adverse drug reactions in Germany: direct costs of internal medicine hospitalizations. Pharmacoepidemiol Drug Saf. 2011;20:626\u201334.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"444_CR39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/emermed-2012-201945","volume":"31","author":"F Ahern","year":"2014","unstructured":"Ahern F, Sahm LJ, Lynch D, McCarthy S. Determining the frequency and preventability of adverse drug reaction-related admissions to an Irish University Hospital: a cross-sectional study. Emerg Med J EMJ. 2014;31:24\u20139.","journal-title":"Emerg Med J EMJ."},{"key":"444_CR40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3233\/JRS-130596","volume":"25","author":"PA Alvarez","year":"2013","unstructured":"Alvarez PA, Bril F, Castro V, Meiville I, Gonzalez CD, Centurion IG, Parejas G, Riera CS, Saubidet CL, Di Girolamo G, Keller GA. Adverse drug reactions as a reason for admission to an internal medicine ward in Argentina. Int J Risk Saf Med. 2013;25:185\u201392.","journal-title":"Int J Risk Saf Med."},{"key":"444_CR41","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2165\/00002018-200831060-00009","volume":"31","author":"M Franceschi","year":"2008","unstructured":"Franceschi M, Scarcelli C, Niro V, Seripa D, Pazienza AM, Pepe G, Colusso AM, Pacilli L, Pilotto A. Prevalence, clinical features and avoidability of adverse drug reactions as cause of admission to a Geriatric Unit\u2014a prospective study of 1756 patients. Drug Saf. 2008;31:545\u201356.","journal-title":"Drug Saf"},{"key":"444_CR42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/pds.667","volume":"11","author":"T Mjorndal","year":"2002","unstructured":"Mjorndal T, Boman MD, Hagg S, Backstrom M, Wiholm BE, Wahlin A, Dahlqvist R. Adverse drug reactions as a cause for admissions to a department of internal medicine. Pharmacoepidemiol Drug Saf. 2002;11:65\u201372.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"444_CR43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","volume":"329","author":"M Pirmohamed","year":"2004","unstructured":"Pirmohamed M, James S, Meakin S, Green C, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ. 2004;329:15\u20139.","journal-title":"BMJ"},{"key":"444_CR44","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pds.1154","volume":"15","author":"M Euler von","year":"2006","unstructured":"von Euler M, Eliasson E, Ohlen G, Bergman U. Adverse drug reactions causing hospitalization can be monitored from computerized medical records and thereby indicate the quality of drug utilization. Pharmacoepidemiol Drug Saf. 2006;15:179\u201384.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"444_CR45","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ejim.2007.06.030","volume":"19","author":"A Alexopoulou","year":"2008","unstructured":"Alexopoulou A, Dourakis SP, Mantzoukis D, Pitsariotis T, Kandyli A, Deutsch M, Archimandritis AJ. Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece. Eur J Intern Med. 2008;19:505\u201310.","journal-title":"Eur J Intern Med."},{"key":"444_CR46","doi-asserted-by":"crossref","first-page":"854862","DOI":"10.1007\/s11096-008-9240-5","volume":"30","author":"Y Hopf","year":"2008","unstructured":"Hopf Y, Watson M, Williams D. Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci. 2008;30:854862.","journal-title":"Pharm World Sci"},{"key":"444_CR47","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2165\/00002512-200926060-00004","volume":"26","author":"P Olivier","year":"2009","unstructured":"Olivier P, Bertrand L, Tubery M, Lauque D, Montastruc JL, Lapeyre-Mestre M. Hospitalizations because of adverse drug reactions in elderly patients admitted through the emergency department: a prospective survey. Drugs Aging. 2009;26:475\u201382.","journal-title":"Drugs Aging"},{"key":"444_CR48","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6904-7-8","volume":"7","author":"KJ Patel","year":"2007","unstructured":"Patel KJ, Kedia MS, Bajpai D, Mehta SS, Kshirsagar NA, Gogtay NJ. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study. BMC Clin Pharmacol. 2007;7:8.","journal-title":"BMC Clin Pharmacol"},{"key":"444_CR49","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/11599430-000000000-00000","volume":"29","author":"R Ruiter","year":"2012","unstructured":"Ruiter R, Visser LE, Rodenburg EM, Trifiro G, Ziere G, Stricker BH. Adverse drug reaction-related hospitalizations in persons aged 55\u00a0years and over: a population-based study in the Netherlands. Drugs Aging. 2012;29:225\u201332.","journal-title":"Drugs Aging"},{"key":"444_CR50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6904-9-8","volume":"9","author":"M Brvar","year":"2009","unstructured":"Brvar M, Fokter N, Bunc M, Mozina M. The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol. 2009;9:8.","journal-title":"BMC Clin Pharmacol"},{"key":"444_CR51","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/bmj.320.7241.1036","volume":"320","author":"P Pouyanne","year":"2000","unstructured":"Pouyanne P, Haramburu F, Imbs JL, Begaud B. Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. French Pharmacovigilance Centres. BMJ. 2000;320:1036.","journal-title":"BMJ."},{"key":"444_CR52","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/pds.1565","volume":"17","author":"CS Hooft van der","year":"2008","unstructured":"van der Hooft CS, Dieleman JP, Siemes C, Aarnoudse AJL, Verhamme K, Stricker BH, Sturkenboom MC. Adverse drug reaction-related hospitalisations: a population-based cohort study. Pharmacoepidemiol Drug Saf. 2008;17:365\u201371.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"444_CR53","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/1472-6963-10-287","volume":"10","author":"P Carrasco-Garrido","year":"2010","unstructured":"Carrasco-Garrido P, de Andres LA, Barrera VH, de Miguel GA, Jimenez-Garcia R. Trends of adverse drug reactions related-hospitalizations in Spain (2001\u20132006). BMC Health Serv Res. 2010;10:287.","journal-title":"BMC Health Serv Res."},{"key":"444_CR54","first-page":"72","volume":"11","author":"WA Tumwikirize","year":"2011","unstructured":"Tumwikirize WA, Ogwal-Okeng JW, Vernby A, Anokbonggo WW, Gustafsson LL, Lundborg SC. Adverse drug reactions in patients admitted on internal medicine wards in a district and regional hospital in Uganda. Afr Health Sci. 2011;11:72\u20138.","journal-title":"Afr Health Sci."},{"key":"444_CR55","first-page":"42","volume":"57","author":"AC Noblat","year":"2011","unstructured":"Noblat AC, Noblat LA, Toledo LA, Santos Pde M, Oliveira MG, Tanajura GM, Spinola SU, Almeida JR. Prevalence of hospital admission due to adverse drug reaction in Salvador, Bahia. Revista Da Associacao Medica Brasileira (1992). 2011;57:42\u20135.","journal-title":"Revista Da Associacao Medica Brasileira (1992)"},{"key":"444_CR56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/pds.871","volume":"12","author":"M Ramesh","year":"2003","unstructured":"Ramesh M, Pandit J, Parthasarathi G. Adverse drug reactions in a south Indian hospital\u2014their severity and cost involved. Pharmacoepidemiol Drug Saf. 2003;12:687\u201392.","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"444_CR57","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00228-002-0467-0","volume":"58","author":"S Schneeweiss","year":"2002","unstructured":"Schneeweiss S, Hasford J, Gottler M, Hoffmann A, Riethling AK, Avorn J. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol. 2002;58:285\u201391.","journal-title":"Eur J Clin Pharmacol"},{"key":"444_CR58","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejim.2013.10.006","volume":"25","author":"YC Chen","year":"2014","unstructured":"Chen YC, Fan JS, Chen MH, Hsu TF, Huang HH, Cheng KW, Yen DH, Huang CI, Chen LK, Yang CC. Risk factors associated with adverse drug events among older adults in emergency department. Eur J Intern Med. 2014;25:49\u201355.","journal-title":"Eur J Intern Med."},{"key":"444_CR59","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1365-2710.2000.00298.x","volume":"25","author":"CF Green","year":"2000","unstructured":"Green CF, Mottram DR, Rowe PH, Pirmohamed M. Adverse drug reactions as a cause of admission to an acute medical assessment unit: a pilot study. J Clin Pharm Ther. 2000;25:355\u201361.","journal-title":"J Clin Pharm Ther"},{"key":"444_CR60","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1472-6904-7-9","volume":"7","author":"H Patel","year":"2007","unstructured":"Patel H, Bell D, Molokhia M, Srishanmuganathan J, Patel M, Car J, Majeed A. Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998\u20132005. BMC Clin Pharmacol. 2007;7:9.","journal-title":"BMC Clin Pharmacol"},{"key":"444_CR61","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s00228-008-0494-6","volume":"64","author":"Y Zopf","year":"2008","unstructured":"Zopf Y, Rabe C, Neubert A, Gassmann KG, Rascher W, Hahn EG, Brune K, Dormann H. Women encounter ADRs more often than do men. Eur J Clin Pharmacol. 2008;64:999\u20131004.","journal-title":"Eur J Clin Pharmacol."},{"key":"444_CR62","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","volume":"365","author":"DS Budnitz","year":"2011","unstructured":"Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365:2002\u201312.","journal-title":"N Engl J Med"},{"key":"444_CR63","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/j.1445-5994.2011.02684.x","volume":"42","author":"YC Chen","year":"2012","unstructured":"Chen YC, Fan JS, Hsu TF, Chen MH, Huang HH, Cheng KW, Yen DH, Huang MS, Lee CH, Chen LK, Yang CC. Detection of patients presenting with adverse drug events in the emergency department. Intern Med J. 2012;42:651\u20137.","journal-title":"Intern Med J."},{"key":"444_CR64","doi-asserted-by":"crossref","first-page":"e13977","DOI":"10.1371\/journal.pone.0013977","volume":"5","author":"KA Hartholt","year":"2010","unstructured":"Hartholt KA, van der Velde N, Looman CW, Panneman MJ, van Beeck EF, Patka P, van der Cammen TJ. Adverse drug reactions related hospital admissions in persons aged 60\u00a0years and over, The Netherlands, 1981\u20132007: less rapid increase, different drugs. PLoS One. 2010;5:e13977.","journal-title":"PLoS One"},{"key":"444_CR65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s002280050738","volume":"56","author":"R Lagnaoui","year":"2000","unstructured":"Lagnaoui R, Moore N, Fach J, Longy-Boursier M, Begaud B. Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability. Eur J Clin Pharmacol. 2000;56:181\u20136.","journal-title":"Eur J Clin Pharmacol"},{"key":"444_CR66","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00228-014-1648-3","volume":"70","author":"SM Matanovic","year":"2014","unstructured":"Matanovic SM, Vlahovic-Palcevski V. Potentially inappropriate prescribing to the elderly: comparison of new protocol to Beers criteria with relation to hospitalizations for ADRs. Eur J Clin Pharmacol. 2014;70:483\u201390.","journal-title":"Eur J Clin Pharmacol"},{"key":"444_CR67","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1345\/aph.1A333","volume":"36","author":"PJ McDonnell","year":"2002","unstructured":"McDonnell PJ, Jacobs MR. Hospital admissions resulting from preventable adverse drug reactions. Ann Pharmacother. 2002;36:1331\u20136.","journal-title":"Ann Pharmacother"},{"key":"444_CR68","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/pds.1663","volume":"18","author":"S Pourseyed","year":"2009","unstructured":"Pourseyed S, Fattahi F, Pourpak Z, Gholami K, Shariatpanahi SS, Moin A, Kazemnejad A, Moin M. Adverse drug reactions in patients in an Iranian department of internal medicine. Pharmacoepidemiol Drug Saf. 2009;18:104\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"444_CR69","first-page":"1255","volume":"96","author":"B Tipping","year":"2006","unstructured":"Tipping B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients\u2014a prospective cross-sectional study. South Afr Med J Suid Afrikaanse Tydskrif Vir Geneeskunde. 2006;96:1255\u20139.","journal-title":"South Afr Med J Suid Afrikaanse Tydskrif Vir Geneeskunde."},{"key":"444_CR70","doi-asserted-by":"crossref","first-page":"163","DOI":"10.6061\/clinics\/2014(03)03","volume":"69","author":"FR Varallo","year":"2014","unstructured":"Varallo FR, Capucho HC, Planeta CD, Mastroianni PD. Possible adverse drug events leading to hospital admission in a Brazilian teaching hospital. Clinics. 2014;69:163\u20137.","journal-title":"Clinics."},{"key":"444_CR71","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s11845-014-1140-1","volume":"184","author":"D Walsh","year":"2015","unstructured":"Walsh D, Lavan A, Cushen AM, Williams D. Adverse drug reactions as a cause of admission to a Dublin-based university teaching hospital. Ir J Med Sci. 2015;184:441\u20137.","journal-title":"Ir J Med Sci"},{"key":"444_CR72","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/phar.1287","volume":"33","author":"C Kongkaew","year":"2013","unstructured":"Kongkaew C, Hann M, Mandal J, Williams SD, Metcalfe D, Noyce PR, Ashcroft DM. Risk factors for hospital admissions associated with adverse drug events. Pharmacotherapy. 2013;33:827\u201337.","journal-title":"Pharmacotherapy."},{"key":"444_CR73","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.mayocp.2013.04.021","volume":"88","author":"W Zhong","year":"2013","unstructured":"Zhong W, Maradit-Kremers H, St Sauver JL, Yawn BP, Ebbert JO, Roger VL, Jacobson DJ, McGree ME, Brue SM, Rocca WA. Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc. 2013;88:697\u2013707.","journal-title":"Mayo Clin Proc."},{"key":"444_CR74","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1111\/j.1365-2125.2012.04310.x","volume":"74","author":"EM Rodenburg","year":"2012","unstructured":"Rodenburg EM, Stricker BH, Visser LE. Sex differences in cardiovascular drug-induced adverse reactions causing hospital admissions. Br J Clin Pharmacol. 2012;74:1045\u201352.","journal-title":"Br J Clin Pharmacol"},{"key":"444_CR75","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(07)61577-3","volume":"370","author":"K Gill","year":"2007","unstructured":"Gill K, Pande R, Malhotra A. Women deliver for development. Lancet. 2007;370:1347\u201357.","journal-title":"Lancet."},{"key":"444_CR76","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2165\/11315790-000000000-00000","volume":"26","author":"A Hellden","year":"2009","unstructured":"Hellden A, Bergman U, von Euler M, Hentschke M, Odar-Cederlof I, Ohlen G. Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study. Drugs Aging. 2009;26:595\u2013606.","journal-title":"Drugs Aging"},{"key":"444_CR77","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1592\/phco.26.5.601","volume":"26","author":"CA Bond","year":"2006","unstructured":"Bond CA, Raehl CL. Adverse drug reactions in United States hospitals. Pharmacotherapy. 2006;26:601\u20138.","journal-title":"Pharmacotherapy."},{"key":"444_CR78","doi-asserted-by":"crossref","first-page":"812","DOI":"10.7326\/0003-4819-136-11-200206040-00009","volume":"136","author":"EJ Thomas","year":"2002","unstructured":"Thomas EJ, Lipsitz SR, Studdert DM, Brennan TA. The reliability of medical record review for estimating adverse event rates. Ann Intern Med. 2002;136:812\u20136.","journal-title":"Ann Intern Med"},{"key":"444_CR79","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/pds.1423","volume":"16","author":"RA Snyder","year":"2007","unstructured":"Snyder RA, Abarca J, Meza JL, Rothschild JM, Rizos A, Bates DW. Reliability evaluation of the adapted national coordinating council medication error reporting and prevention (NCC MERP) index. Pharmacoepidemiol Drug Saf. 2007;16:1006\u201313.","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Drug Safety"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-016-0444-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40264-016-0444-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40264-016-0444-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T14:31:27Z","timestamp":1656858687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40264-016-0444-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,23]]},"references-count":79,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["444"],"URL":"https:\/\/doi.org\/10.1007\/s40264-016-0444-7","relation":{},"ISSN":["0114-5916","1179-1942"],"issn-type":[{"value":"0114-5916","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,23]]}}}